The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) is a clinical study sponsored by the National Heart, Lung, and Blood Institute (NHLBI). PrecISE's physician scientists are dedicated to researching better treatments for people living with severe asthma.
PrecISE is a clinical study that uses precision medicine for severe asthma. Precision medicine is an approach to the prevention and treatment of disease that uses information about an individual's or group's specific disease process, symptoms, and treatment responses, to identify the medicines and therapies that are most likely to be effective for them.
Researchers from over 30 locations across the US, as well as sites in Canada and the UK, are involved in PrecISE. See the map below. Click on a state for a list of study sites by city.